Canada Marijuana News

Female-focused marijuana company first to offer clones in Canada

Ontario-based Natural MedCo has become the first company in Canada to offer marijuana clones for sale to legal recreational consumers, achieving a first-mover advantage for an untapped and underserved consumer segment. Natural MedCo’s Eve brand – which bills itself as “Canada’s premier cannabis brand for all women” – succeeded in getting its clones to market in […]

Read More

Cannabis shortages plague Canadian retailers; here’s how they’re responding

As the Canadian cannabis industry struggles to provide enough supply to meet exuberant demand since recreational use became legal, private retailers are faced with their own challenge: how to stay in business. Many store owners in Alberta, Manitoba and Newfoundland have closed their doors as they await marijuana shipments, while others are considering different courses […]

Read More

Canopy Growth boosts M&A transparency in wake of Aphria fiasco

Cash-rich Canopy Growth bought global vaporizer leader Storz & Bickel for 220 million Canadian dollars ($160 million) in a bid to improve its portfolio of intellectual property. The all-cash deal is also intended to position Canopy to capitalize on the next wave of federally regulated products in Canada and around the world, the Smiths Falls, Ontario company […]

Read More

Acreage inks $160 million acquisition of Oregon cannabis firm

Acreage Holdings has inked a $160 million deal to acquire Form Factory, a Portland, Oregon-based marijuana infused edibles manufacturer and distributor. The all-stock deal will boost Acreage’s footprint from 18 to 19 states and position the firm as a multistate consumer packaged goods firm, said George Allen, president of the New York-based company (CSE: ACRG.U). […]

Read More

Marlboro maker, Cronos join forces in exclusive CA$2.4 billion deal to tap global cannabis opportunities

Altria Group, one of the largest tobacco companies in North America, has agreed to invest 2.4 billion Canadian dollars ($1.8 billion) in Ontario-based cannabis producer Cronos Group – the most significant foray by Big Tobacco into the rapidly growing cannabis industry to date.

Altria also agreed to make Cronos its exclusive partner for international cannabis opportunities.

Read More

Key UN summit could lead to international rescheduling of cannabis

A crucial milestone for the global industry could be achieved this week, as the World Health Organization (WHO) presents its findings on cannabis to the Commission on Narcotic Drugs (CND) in Vienna. The CND reconvened its 61st session on Dec. 5. The WHO’s Expert Committee on Drug Dependence (ECDD) held meetings in June and November dedicated to pre-review and review […]

Read More

Regulator warns Canadian marijuana firms against ‘problematic practices’

Canada’s stock market regulator warned publicly traded companies in emerging industries such as cannabis and fintech against “problematic promotional activities” that could artificially increase share prices and put investors at risk. The warning from the Canadian Securities Administrators (CSA) – an umbrella organization for provincial securities regulators – came amid already highly volatile cannabis stock […]

Read More

IGC Resources, Westleaf Cannabis close CA$20M raise, including Tilray investment

Alberta marijuana companies IGC Resources (TSXV: IGC.H) and Westleaf Cannabis closed a brokered private placement of 20 million Canadian dollars ($15 million), including CA$2.9 million from British Columbia-based Tilray. The capital raise was completed in connection with Westleaf’s proposed reverse takeover of IGC, which received conditional approval from the TSX Venture Exchange. The company plans to […]

Read More

Aphria fallout: 5 takeaways on the report that sent this cannabis stock plunging

The blows to Aphria’s stock continued Wednesday as the Canadian cannabis giant’s share price tumbled in the wake of a scathing short-seller report. Aphria’s stock (Nasdaq: APHA) closed Wednesday at $4.51 – down more than 25% for the day. The company has been on the defensive since Monday, refuting claims lobbed by short sellers Quintessential […]

Read More

Aphria warned by Health Canada about ‘noncompliance’ in June

Beleaguered Canadian cannabis giant Aphria was given a noncompliance rating and issued a warning letter by Health Canada in June over “critical” findings discovered in a routine annual inspection. During the inspection, Health Canada identified three critical items related to recordkeeping, good production practices and sanitation and maintenance of Aphria’s facility in Leamington, Ontario, the […]

Read More